BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15882151)

  • 1. Protecting the patient from saphenous vein graft intervention.
    Stone GW
    J Interv Cardiol; 2005 Apr; 18(2):77-9. PubMed ID: 15882151
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 4. Rebuttal: innovative embolic protection strategies for saphenous vein graft interventions.
    Badhey N; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):595. PubMed ID: 21351236
    [No Abstract]   [Full Text] [Related]  

  • 5. Saphenous vein graft disease: a left main equivalent.
    Kandzari DE; Sketch MH
    J Invasive Cardiol; 2001 Sep; 13(9):665-8. PubMed ID: 11533510
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal therapy for degenerated saphenous vein graft disease.
    Kramer B
    J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of balloon angioplasty and stents in the management of failed arterial reconstructions.
    Schneider PA; Andros G
    Semin Vasc Surg; 1994 Sep; 7(3):178-82. PubMed ID: 7812493
    [No Abstract]   [Full Text] [Related]  

  • 8. Do we still need distal protection in the treatment of SVG disease?
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):804-5. PubMed ID: 19009627
    [No Abstract]   [Full Text] [Related]  

  • 9. Low frequency of embolic protection devices in saphenous vein intervention: a matter of lack of conviction?
    Lozano I; Rondan J; Avanzas P; Suarez CP
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):E4. PubMed ID: 20853360
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population.
    Webb LA; Dixon SR; Safian RD; O'Neill WW
    J Interv Cardiol; 2005 Apr; 18(2):73-5. PubMed ID: 15882150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebuttal: Use of embolic protection devices in saphenous vein graft interventions: the ongoing challenge.
    Badhey N; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):E5-6. PubMed ID: 20853356
    [No Abstract]   [Full Text] [Related]  

  • 12. Embolic protection devices in saphenous percutaneous intervention.
    Morís C; Lozano I; Martín M; Rondán J; Avanzas P
    EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The embolic protection toolbox.
    Wahr DW; Rogers C
    J Interv Cardiol; 2005 Apr; 18(2):81-2. PubMed ID: 15882152
    [No Abstract]   [Full Text] [Related]  

  • 14. Saphenous Vein Graft Interventions.
    Lee MS; Manthripragada G
    Interv Cardiol Clin; 2016 Apr; 5(2):135-141. PubMed ID: 28582199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saphenous vein graft recanalization without embolic protection: impossible is nothing.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):70-1. PubMed ID: 21681894
    [No Abstract]   [Full Text] [Related]  

  • 16. Yes reflow.
    Heldman AW; Brinker JA
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):404-5. PubMed ID: 10470467
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts.
    Blackman DJ; Choudhury RP; Banning AP; Channon KM
    J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial.
    Dixon SR; Mann JT; Lauer MA; Casale PN; Dippel EJ; Strumpf RK; Feldman RL; Shear W; Resar JR; Zimmer SD; O'Neill WW;
    J Interv Cardiol; 2005 Aug; 18(4):233-41. PubMed ID: 16115151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.